Free Trial

Relay Therapeutics (RLAY) SEC Filings & 10K Form

Relay Therapeutics logo
$2.72 -0.27 (-9.03%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$2.78 +0.06 (+2.17%)
As of 03/28/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Relay Therapeutics SEC Filings

DateFilerForm TypeView
03/20/2025
5:13 PM
Point72 Asset Management, L.P. (Filed by)
Relay Therapeutics (Subject)
Form SCHEDULE 13G
02/26/2025
3:10 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
7:56 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Relay Therapeutics (Subject)
Form SCHEDULE 13G/A
01/30/2025
8:02 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
8:06 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
8:10 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
8:16 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
6:01 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:03 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
3:04 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
8:00 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
8:00 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
8:00 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
8:00 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
8:00 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:30 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
7:35 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:01 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:18 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
6:00 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:07 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:08 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:09 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:09 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:05 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:45 PM
Relay Therapeutics (Filer)
Form 424B5
09/11/2024
3:49 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:43 PM
Relay Therapeutics (Filer)
Form 424B5
09/09/2024
7:00 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
4:23 PM
Relay Therapeutics (Filer)
Form S-3ASR
08/06/2024
3:15 PM
Relay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
5:42 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:42 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:43 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:43 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

07/31/2024
3:06 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
5:37 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2024
3:24 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
3:29 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2024
3:47 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:05 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:15 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
3:38 PM
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:41 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:41 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:42 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:43 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:18 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2024
7:00 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
7:01 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:02 PM
HILL LINDA A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:03 PM
Borisy Alexis (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:03 PM
INGRAM DOUGLAS S (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:04 PM
Kathiresan Sekar (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:04 PM
Relay Therapeutics (Issuer)
Rubin Jami (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:05 PM
Relay Therapeutics (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:05 PM
Murcko Mark (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:12 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:15 PM
Relay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
7:30 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:31 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:33 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:36 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:05 PM
Relay Therapeutics (Filer)
Form DEF 14A
04/23/2024
3:10 PM
Relay Therapeutics (Filer)
Form DEFA14A
04/23/2024
3:15 PM
Relay Therapeutics (Filer)
Form ARS
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:RLAY) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners